Category: Pediatric Rehabilitation; Neuroplasticity (includes neuroscience); Brain Injury
A. To investigate and provide adaptive limb training for children with hemiparesis from ABI using a bimanual-to unimanual training approach. We hypothesize that child-friendly upper limb robotic-training will lead to improved motor outcomes on the Assisting Hand Assessment (AHA), Jebsen-Taylor-Test-of-Hand-Function (JTTHF), and Box&Blocks test (BBT).
B. To improve the understanding of the pattern of recovery of isolated joint movements in the pediatric population with hemiparesis following ABI. We hypothesize that individuals receiving device-based bimanual-to-unimanual training will show improvement in active range of motion across upper limb joints.
Clinical, pilot feasibility study that utilizes a robotic device: Bimanual Arm Trainer (BAT, MirroredMotionWorks,NC). This device employs mirrored motion, combines motivational features with modern technology and a therapeutic method that links the movement of the arms to retrain a patient’s brain. Feedback and motivation are provided through age-appropriate gaming modules. It provides training of simultaneous shoulder external rotation and elbow extension. Training of pronation, supination and grasp/release also collected. All kinematic measures recorded during training.
This study is taking place as part of the Burke-Blythedale Pediatric Neuroscience Research Collaboration in Westchester,NY. (Takes place at Blythedale Children's Hospital,Valhalla,NY)
Participants (or Animals, Specimens, Cadavers) : Children (n=10, ages 5-17 years) with hemiparesis due to ABI. Recruited/enrolled through past research participation and/or referred by hospital clinicians.
Primary motor outcome assessments collected at all timepoints (Baseline,Pre-test,Post-test). Intervention: bimanual robotic training 2x/week over 9 weeks. Sessions are 45-minutes in duration.
Main Outcome Measure(s) : AHA, BBT, JTTHF
Results : Preliminary results show that bimanual use (AHA, p
These results are favorable and significant but further study is needed. No adverse events occurred.